Temasek Holdings’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$102M Hold
2,399,426
0.27% 68
2026
Q1
$151M Buy
2,399,426
+317,800
+15% +$25.4M 0.49% 40
2025
Q4
$198M Buy
2,081,626
+402,300
+24% +$39.4M 0.63% 29
2025
Q3
$164M Buy
1,679,326
+593,915
+55% +$61.5M 0.57% 32
2025
Q2
$117M Hold
1,085,411
0.45% 32
2025
Q1
$109M Buy
1,085,411
+678,917
+167% +$68.4M 0.44% 35
2024
Q4
$36.3M Buy
+406,494
New +$35.8M 0.14% 58
2021
Q1
Sell
-232,545
Closed -$8.36M 73
2020
Q4
$8.36M Buy
+232,545
New +$8.38M 0.04% 65

Other funds holding BSX

Temasek Holdings's BSX Position: Q2 2026 in Review

Temasek Holdings held its Boston Scientific (BSX) position steady in Q2 2026 at 2,399,426 shares worth $102M. The position accounts for 0.27% of the portfolio, ranked #68.

Temasek Holdings first reported a position in BSX in Q4 2020 and has held it in 8 quarters since. The position peaked at $198M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Temasek Holdings held 2,399,426 shares of Boston Scientific worth $102M as of Q2 2026.
  • Temasek Holdings left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.27% of Temasek Holdings's portfolio in Q2 2026, its #68 holding.
  • Temasek Holdings first reported a position in Boston Scientific in Q4 2020 and has held it in 8 quarters since.
  • Temasek Holdings's Boston Scientific position peaked at $198M in Q4 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Temasek Holdings's 13F filing for Q2 2026, filed 7 Aug 2026.